Nike maps out new growth strategy, sets 2031 financial targets
Nike outlined a growth strategy targeting $5 billion in incremental revenue by 2031, with operating margins of 12-14% and adjusted EPS of $3.00-$3.50. For the current period, it expects high-single-digit revenue decline and adjusted EPS of $1.15-$1.35, excluding restructuring costs.
How this was made

The 30-second read
Why it matters
The disclosure updates the earnings trajectory traders use for discounting, with a clear split between long-term upside (incremental revenue growth, higher adjusted EPS by 2031) and near-term pressure (high-single-digit revenue decline, adjusted operating margin around 6%).
Market read
This is a guidance-style strategic update that can reprice Nike’s growth and margin recovery path, especially given the stated near-term EPS and margin outlook.
What to watch
The article notes restructuring expense exclusions and a specific adjusted EPS bridge, so traders may need to reconcile how much of the near-term weakness is one-time versus operational.
Background
Nike outlines a new growth strategy with explicit end-of-2031 financial targets and an outlook that anticipates revenue and operating income declines before that endpoint.
Ticker impact
Nike sets 2031 targets, including $5B incremental revenue growth and adjusted EPS of $3.00 to $3.50, plus a weaker near-term EPS outlook.
Likely mixed reaction as investors weigh ambitious 2031 targets against the stated high-single-digit revenue decline and lower adjusted EPS range.
The article discloses explicit multi-year financial targets and a near-term EPS/margin deterioration, which can reprice both growth credibility and near-term earnings expectations.
Market effects
Could influence discretionary apparel peers’ valuation frameworks by reinforcing a margin recovery narrative tied to a multi-year growth plan.
Limited direct regional read-through; impacts are primarily global consumer discretionary sentiment.
Multi-year guidance can affect global footwear/apparel sector risk premia, but the article provides no macro linkage beyond company targets.
Counterpoint
Investors may treat the 2031 targets as aspirational and focus on the near-term adjusted EPS range and margin compression, which could dominate valuation.
Key entities
- companyNike, Inc.
Sets 2031 incremental revenue growth, operating margin, and adjusted EPS targets, while projecting near-term revenue and operating income declines.
